Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Venture Life ( (GB:VLG) ).
Venture Life Group has repurchased 46,963 ordinary shares at a volume-weighted average price of 69.72 pence under its ongoing share buyback programme, with the stock to be held in treasury. Following this transaction, the company has 128,860,145 ordinary shares in issue, of which 5,458,213 are held in treasury, leaving 123,401,932 voting rights, a figure investors will use to calculate disclosure thresholds under UK transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Spark’s Take on GB:VLG Stock
According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.
Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.
To see Spark’s full report on GB:VLG stock, click here.
More about Venture Life
Venture Life Group is a UK-headquartered international consumer self-care company focused on proactive healthy longevity. Its portfolio spans women’s intimate health brand Balance Activ, ENT care product Earol, Lift and Glucogel for energy and glucose management and hypoglycaemia, and Health & Her supplements supporting the hormonal lifecycle, sold via retail, pharmacy and e-commerce channels worldwide.
Average Trading Volume: 323,252
Technical Sentiment Signal: Buy
Current Market Cap: £85.88M
See more data about VLG stock on TipRanks’ Stock Analysis page.

